Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 14/20 | 0.64 |
| ▸ | OPRK1 | P41145 | 14/20 | 0.64 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.60 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.60 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.58 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.58 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.58 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.56 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29903316 | 0.88 | NPY2R (0.64) | EPHA2CXCR4 | |
| SCHEMBL30544090 | 0.88 | OPRM1 (0.57) | OPRM1OPRK1NMUR2NMUR1MAPK8 | |
| SCHEMBL29856103 | 0.88 | TFPI (0.60) | OPRM1OPRK1EPHA2 | |
| SCHEMBL29828704 | 0.87 | NMUR2 (0.62) | NMUR2NMUR1MAPK8MAPK9MAPK10 | |
| SCHEMBL30924747 | 0.87 | MAPK8 (0.61) | NMUR2NMUR1MAPK8MAPK9MAPK10 | |
| SCHEMBL30799488 | 0.87 | OPRM1 (0.57) | OPRM1OPRK1NMUR2NMUR1EPHA2 | |
| SCHEMBL30924728 | 0.87 | EPHA2 (0.65) | NMUR2NMUR1MAPK8MAPK9MAPK10 | |
| SCHEMBL31529692 | 0.86 | CALCR (0.59) | OPRM1OPRK1MAPK8MAPK9MAPK10 | |
| SCHEMBL31529687 | 0.86 | CALCR (0.59) | OPRM1OPRK1MAPK8MAPK9MAPK10 | |
| SCHEMBL30973963 | 0.86 | OPRM1 (0.64) | OPRM1OPRK1NMUR2NMUR1EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200297633-A1 | PEPTIDE-TARGETED LIPOSOMAL DELIVERY FOR TREATMENT, DIAGNOSIS, AND IMAGING OF DISEASES AND DISORDERS | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2020-09-24 | — | — | US | disclosed |